2013 Sponsors & Exhibitors

Platinum Sponsor

 

 

 

 

Gold Sponsor

 

 

 

 

Silver Sponsor

 

 

 

Corporate Members

                                                                                                                                                       

                                                                                           

 

 

 

Product Theater Sponsors

 

 

 

 

 

 

 

 

 

Exhibitors

Academy of Oncology Nurse Navigators® (AONN) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of nearly 3000 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end; we support and serve our members.

 

American Health & Drug Benefits® examines drug and other healthcare intervention value from the separate and unified vantage points of each stakeholder group to the process: payers, purchasers, providers, patients, manufacturers, regulators, distributors, and evaluators. Directly or indirectly, all parties to healthcare benefits influence policy and demand satisfaction of their interests.

 

Association for Value-Based Cancer Care is the fastest growing national specialty organization dedicated to improving the care of cancer patients and their quality of life, by discussing, considering, and evaluating the value equation as it relates to new and existing cancer therapies. This organization, which currently consists of more than 450 members, was established to provide a network for payers and oncology healthcare professionals to interact and network to promote optimal care for patients and their families.

Bentelligence aims to apply healthcare management intelligence to today’s complex healthcare business decisions.

Bentelligence offers innovative healthcare market research, strategic direction and business intelligence to help clients understand their markets and stakeholders.  Led by a team of noted industry experts, Bentelligence primary mission is to provide actionable deliverables, using highly experienced talent and data sources that are targeted, accurate and timely.  Based in Monroe, Connecticut and Greenville, SC the company works with leading pharmaceutical and device manufacturers, health plans and other organizations working in the healthcare industry today and boasts a proven track-record of success. For additional information, visit www.bentelligence.com.

 

 

Celgene Corporation is a global biopharmaceutical company that is helping healthcare providers turn incurable cancers into chronic, manageable diseases through innovative therapies. This dedication to medical progress goes hand-in-hand with our industry-leading patient support and access programs. Together, these aspects form the core of our commitment to patients worldwide. For more information, visit www.celgene.com.

 

Center of Excellence Media, LLC (COE) was founded in November 2007 and is approved by the ACCME as a noncommercial interest, nonaccredited provider/joint sponsor of continuing medical education. As a nonaccredited joint sponsor, COE collaborates with several accredited provider partners, including universities and nonprofit medical education companies. These partnerships and COE’s strict adherence to the ACCME Standards for Commercial Support ensure that all of the educational programs produced by COE are objective, balanced, scientifically rigorous, and free of commercial bias. The philosophy of COE is to engage learners using multiple platforms (eg, national, regional, and local conferences and symposia; print supplements and newsletters; and interactive online activities) to increase the overall impact of each activity. COE has developed and implemented more than 200 activities with 10 different accredited providers and more than a dozen medical societies/associations. Through its efforts, COE has delivered more than 300 hours of course instruction to greater than 210,000 healthcare professionals, with over 20,000 continuing medical education credits issued.

 

Diplomat Specialty Pharmacy, an independently held healthcare company dedicated to being a customer-focused and innovative partner, provides medication management, disease management, and clinical services in a caring, supportive environment.

 

DK Pierce & Associates is a certified Women’s Business Enterprise focusing on patient access to care for novel drugs/devices and services by facilitating communication between all stakeholders in the healthcare environment. The company’s consulting leadership team has more than 100+ cumulative years in biopharmaceutical, device, payer, and healthcare consulting organizations.

Eisai Inc. is the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.  Headquartered in Woodcliff Lake, New Jersey, Eisai’s key areas of commercial focus include neurology, oncology and metabolic disorders.  For more information about Eisai Inc., please visit us at www.eisai.com.
 

Janssen Biotech, Inc. redefines the standard of care in immunology, oncology, urology and nephrology.Built upon a rich legacy of innovative firsts, Janssen Biotech has delivered on the promise of new treatments and ways to improve the health of individuals with serious disease. Beyond its innovative medicines, Janssen Biotech is at the forefront of developing education and public policy initiatives to ensure patients and their families, caregivers, advocates and health care professionals have access to the latest treatment information, support services and quality care. For more information on Janssen Biotech, Inc. or its products, visit www.janssenbiotech.com.

 

Journal of Hematology Oncology Pharmacy™ is an independent, peer-reviewed journal founded in 2011 to provide hematology and oncology pharmacy practitioners and other healthcare professionals with high-quality peer-reviewed information relevant to hematologic and oncologic conditions to help them optimize drug therapy for patients.

 

OncologyExpress, a division of Innovatix, is part of the first GPO specifically dedicated to advocating on behalf of oncologists. We help thousands of oncologists nationwide enhance quality of care while improving operating margins. Through our affiliation with Premier, we offer our members access to a $36 billion portfolio of products and services.

 

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Massachusetts, markets VELCADE, a first-in-class proteasome inhibitor, and has a robust clinical development pipeline of product candidates. Millennium Pharmaceuticals, Inc. was acquired by Takeda Pharmaceutical Company Ltd. in May 2008. The company’s research, development, and commercialization activities are focused in oncology. Additional information about Millennium is available through its website, www.millennium.com.

 

Onco360™ is an oncology pharmaceutical services company dedicated to advancing the continuum of pharmaceutical cancer care. Onco360 provides pharmacy solutions to oncologists, payers, hospitals, and NCCN Centers of Excellence through certified and JCAHO-accredited OncoMed pharmacies. These services include robust clinical management, compounding, dispensing, and financial, administrative, and compliance support.

 

Personalized Medicine in Oncology™ (PMO) is a peer-reviewed journal serving the informational needs of oncologists related to precision medicine and the next generation of oncologic care.

 

 

Reimbursement Intelligence (RI) is a firm focused on driving access and reimbursement for pharma and biotech clients.  Our team focuses on understanding the reimbursement landscape and continuing market events through our research team and analytic tools. RI delivers strategic and tactical solutions throughout the product lifecycle. RI was formed in response to the growing demand for streamlined reimbursement strategies that would connect patients, payers, and healthcare providers to medical innovations.

 

The Oncology Nurse-APN/PA® (TON) features articles written by and for oncology nurses and specifically addresses the issues nurses and their colleagues face every day in clinical practice. In addition to news on the latest research findings and results of large clinical trials, issues include interviews with thought leaders, articles of interest to student nurses, and articles on lifestyle topics, such as nutrition, stress management, personal finance, and communication and time management skills. Through its partnerships, TON offers readers the opportunity to earn FREE CE credits each month by completing the continuing education activity included in each issue.

 

The Oncology Pharmacist® (TOP) features articles written by and for oncology pharmacists and specifically addresses the issues pharmacists and their colleagues face every day in clinical practice in a quick, easy-to-read format. In addition to news on the latest research findings and results of large clinical trials, issues include interviews with thought leaders, articles of interest to pharmacy students and residents, and articles on practice management. TOP offers readers the opportunity to earn FREE CE credits each month by completing the continuing education activity included in each issue.

 

Value-Based Care in Myeloma™ is an online resource center developed by Value-Based Cancer Care® in collaboration with the Association for Value-Based Cancer Care and other partner organizations. This resource center provides payers, providers, and the entire oncology team with information relevant to the management of patients with multiple myeloma. Features include interviews with experts, highlights from major medical conferences, and much more.